Mission Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Hold
0
620

Other funds holding LLY

Mission Wealth Management's LLY Position: Q2 2026 in Review

Mission Wealth Management increased its Eli Lilly (LLY) stake by 72% in Q2 2026, buying an estimated $11M and bringing the position to 25,625 shares worth $30.7M. The position accounts for 0.38% of the portfolio, ranked #44.

Mission Wealth Management first reported a position in LLY in Q3 2015 and has held it in 44 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mission Wealth Management held 25,625 shares of Eli Lilly worth $30.7M as of Q2 2026.
  • Mission Wealth Management bought 10,718 Eli Lilly shares in Q2 2026, an estimated $11M.
  • Eli Lilly made up 0.38% of Mission Wealth Management's portfolio in Q2 2026, its #44 holding.
  • Mission Wealth Management first reported a position in Eli Lilly in Q3 2015 and has held it in 44 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mission Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.